InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-7.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Manning Donald C., Directeur Médical. Director active across 1 company, notably Pacira BioSciences, Inc.. Cumulatively, 6 reports have been recorded. Split: 0 buy · 4 sells. Total volume traded: €503k. History available since 2 June 2021. The latest transaction was filed on 9 June 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations6 total
6,000 shares0Common StockSEC:0001209191-21-040088:0
6,000 shares0Common StockSEC:0001209191-21-040088
2,600 shares@ US$61.140.012% mcap25.9% of flowCommon StockSEC:0001209191-21-039610:0
2,600 shares@ US$61.1425.9% of flowCommon StockSEC:0001209191-21-039610
2,380 shares@ US$62.1230.011% mcap24.1% of flowCommon StockSEC:0001209191-21-038328:0
2,380 shares@ US$62.12324.1% of flowCommon StockSEC:0001209191-21-038328
6 of 6 declarations
About Manning Donald C.
Donald C. Manning is the Chief Medical Officer at Pacira BioSciences, Inc. He is responsible for overseeing the company's medical initiatives and research and development strategy. His clinical expertise and experience in the pharmaceutical sector are essential for guiding the company's innovation efforts.
